Data / Form D filings / Serimmune Inc.
Serimmune Inc.: Form D filings
Serimmune Inc., a biotechnology company in Goleta, CA, filed 8 Form D notices with the SEC between 2017 and 2023. The latest, on November 15, 2023, reports $11.5 million sold of a $16.5 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 150 CASTILIAN DRIVE, SUITE 100, Goleta, CA, 93117
- Phone
- (805) 650-5229
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1693808
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 15, 2023 | Amendment | $16,500,000 | $11,512,176 | $4,987,824 | 2 | Oct 31, 2023 | sec.gov |
| Aug 21, 2023 | Amendment | $15,000,000 | $10,612,176 | $4,387,824 | 2 | Jul 24, 2023 | sec.gov |
| Dec 1, 2022 | Amendment | $13,500,000 | $9,535,454 | $3,964,546 | 3 | Jul 21, 2021 | sec.gov |
| Jul 12, 2022 | Amendment | $9,000,000 | $5,685,168 | $3,314,832 | 3 | Jul 21, 2021 | sec.gov |
| Aug 11, 2021 | New notice | $7,000,000 | $4,362,861 | $2,637,139 | 3 | Jul 2, 2021 | sec.gov |
| Sep 11, 2020 | New notice | $23,312,065 | $12,048,253 | $11,263,812 | 7 | Aug 27, 2020 | sec.gov |
| Jun 5, 2019 | New notice | $7,000,000 | $1,406,111 | $5,593,889 | 5 | May 22, 2019 | sec.gov |
| Jan 5, 2017 | New notice | $8,000,000 | $2,500,522 | $5,499,478 | 7 | Dec 21, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Malek Faham | Executive Officer, Director | |
| Kirstin Loomis | Director | |
| Nicholas Naclerio | Director | |
| Bill Welch | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Nov 13, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Serimmune Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.